| Dr Mitchell Walton Beckert, MD | |
|
1260 Innovation Pkwy Ste 100, Greenwood, IN 46143-3602 | |
| (317) 884-5200 | |
| (317) 884-5360 |
| Full Name | Dr Mitchell Walton Beckert |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 7 Years |
| Location | 1260 Innovation Pkwy Ste 100, Greenwood, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235669573 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 01089461A (Indiana) | Primary |
| 207X00000X | Orthopaedic Surgery | 35.145468 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana Orthopaedic Hospital, Llc | Indianapolis, IN | Hospital |
| Community Hospital South, Inc. | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedics-indianapolis Inc | 7416860663 | 169 |
News Archive
Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
Stony Brook University Hospital was named as one of America's Most Beautiful Hospitals, ranking third in a list of 50 healthcare facilities around the country. Soliant Health, a leading specialty healthcare provider, released the results this month of the 20 Most Beautiful Hospitals 2011, a contest developed by Soliant Health.
New York lawmakers unanimously approved legislation Monday that will require doctors to issue drug prescriptions electronically within three years, meanwhile establishing tighter restrictions on painkillers and other addictive drugs on the state list of controlled substances.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
› Verified 5 days ago
| Entity Name | Orthopaedics-indianapolis Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336252451 PECOS PAC ID: 7416860663 Enrollment ID: O20031124000328 |
News Archive
Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
Stony Brook University Hospital was named as one of America's Most Beautiful Hospitals, ranking third in a list of 50 healthcare facilities around the country. Soliant Health, a leading specialty healthcare provider, released the results this month of the 20 Most Beautiful Hospitals 2011, a contest developed by Soliant Health.
New York lawmakers unanimously approved legislation Monday that will require doctors to issue drug prescriptions electronically within three years, meanwhile establishing tighter restrictions on painkillers and other addictive drugs on the state list of controlled substances.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mitchell Walton Beckert, MD 8450 Northwest Blvd, Indianapolis, IN 46278-1381 Ph: (317) 802-2000 | Dr Mitchell Walton Beckert, MD 1260 Innovation Pkwy Ste 100, Greenwood, IN 46143-3602 Ph: (317) 884-5200 |
News Archive
Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
Stony Brook University Hospital was named as one of America's Most Beautiful Hospitals, ranking third in a list of 50 healthcare facilities around the country. Soliant Health, a leading specialty healthcare provider, released the results this month of the 20 Most Beautiful Hospitals 2011, a contest developed by Soliant Health.
New York lawmakers unanimously approved legislation Monday that will require doctors to issue drug prescriptions electronically within three years, meanwhile establishing tighter restrictions on painkillers and other addictive drugs on the state list of controlled substances.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
› Verified 5 days ago
Mark J Dilella, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1260 Innovation Pkwy #100, Greenwood, IN 46143 Phone: 317-884-5200 Fax: 317-884-5360 | |
Thomas S Woo, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1260 Innovation Pkwy, #100, Greenwood, IN 46143 Phone: 317-884-5200 Fax: 317-884-5360 | |
Dr. Hiram Jeffery Whitaker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1260 Innovation Pkwy, #100, Greenwood, IN 46143 Phone: 317-884-5200 Fax: 317-884-5360 | |
Dr. Matthew R Lavery, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1260 Innovation Pkwy, #100, Greenwood, IN 46143 Phone: 317-884-5200 Fax: 317-884-5360 | |
Dr. Christy Faye Kellams, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1260 Innovation Pkwy Ste 100, Greenwood, IN 46143 Phone: 317-802-2000 | |
Dr. Robert H Falender, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1260 Innovation Pkwy, #100, Greenwood, IN 46143 Phone: 317-884-5200 Fax: 317-884-5360 |